Back to Agenda
Improving Access to Medicines: Exploring New Regulatory Frameworks for Letting Data Lead the Way to Increased Drug Options
Session Chair(s)
Nancy Bradish Myers, JD
CEO and Founder
Catalyst Healthcare Consulting, Inc, United States
Modern regulation is needed to promote data sharing and development of innovative tools that increase market competition and availability of effective, affordable drugs. The panel will explore approaches to harnessing the potential of global data
Learning Objective : Describe issues revealed by the COVID-19 pandemic of drug accessibility in the EU, and analyze the potential impact of leveraging global data sources to increase drugs options and reduce costs for patients. Discuss how the COVID-19 pandemic created opportunities in data sharing to improve patient access. Propose regulatory solutions for leveraging data to increase industry competition.
Speaker(s)
Panelist
Melanie Nallicheri
EQRx, United States
President
Panelist
Karen Taylor
Deloitte, United Kingdom
Research Director of the Deloitte UK Centre for Health Solutions
Panelist
Entela Xoxi, PharmD, PhD, MSc
Independent Consultant & Academic Research At Catholic University of Rome 'sacro, Italy
Senior Scientific Advisor & Research fellow
Have an account?